VTechWorks staff will be away for the Thanksgiving holiday beginning at noon on Wednesday, November 27, through Friday, November 29. We will resume normal operations on Monday, December 2. Thank you for your patience.
 

Modeling the Influence of Vaccine Administration on COVID-19 Testing Strategies

dc.contributor.authorForde, Jonathan E.en
dc.contributor.authorCiupe, Stanca M.en
dc.date.accessioned2022-01-04T13:50:02Zen
dc.date.available2022-01-04T13:50:02Zen
dc.date.issued2021-12-19en
dc.date.updated2021-12-23T15:06:28Zen
dc.description.abstractVaccination is considered the best strategy for limiting and eliminating the COVID-19 pandemic. The success of this strategy relies on the rate of vaccine deployment and acceptance across the globe. As these efforts are being conducted, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is continuously mutating, which leads to the emergence of variants with increased transmissibility, virulence, and resistance to vaccines. One important question is whether surveillance testing is still needed in order to limit SARS-CoV-2 transmission in a vaccinated population. In this study, we developed a multi-scale mathematical model of SARS-CoV-2 transmission in a vaccinated population and used it to predict the role of testing in an outbreak with variants of increased transmissibility. We found that, for low transmissibility variants, testing was most effective when vaccination levels were low to moderate and its impact was diminished when vaccination levels were high. For high transmissibility variants, widespread vaccination was necessary in order for testing to have a significant impact on preventing outbreaks, with the impact of testing having maximum effects when focused on the non-vaccinated population.en
dc.description.versionPublished versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.citationForde, J.E.; Ciupe, S.M. Modeling the Influence of Vaccine Administration on COVID-19 Testing Strategies. Viruses 2021, 13, 2546.en
dc.identifier.doihttps://doi.org/10.3390/v13122546en
dc.identifier.urihttp://hdl.handle.net/10919/107339en
dc.language.isoenen
dc.publisherMDPIen
dc.rightsCreative Commons Attribution 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en
dc.subjectCOVID-19 vaccinationen
dc.subjectDelta varianten
dc.subjectmathematical modelingen
dc.subjecttestingen
dc.subjectmulti-scale modelsen
dc.titleModeling the Influence of Vaccine Administration on COVID-19 Testing Strategiesen
dc.title.serialVirusesen
dc.typeArticle - Refereeden
dc.type.dcmitypeTexten

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
viruses-13-02546-v2.pdf
Size:
752.41 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description: